Third Avenue Management LLC Amgen Inc Transaction History

Third Avenue Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $36.7 Million - $42.9 Million	-216,733 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.12 Million - $1.25 Million	6,609 Added 3.15%	216,733 $37.7 Million
Q3 2017 Oct 26, 2017	SELL	$167.29 - $191.0 $51,190 - $58,446	-306 Reduced 0.15%	210,124 $39.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	210,430	210,430 $0

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Third Avenue Management LLC, based on Form 13F filings with the SEC.

Stay updated on Third Avenue Management LLC with notifications on news.